HCPCS Level II Q5161: Denosumab-kyqq (Aukelso/Bosaya) injection, 1 mg
HCPCS Level II code Q5161 describes a single 1 mg injection of denosumab-kyqq (Aukelso/Bosaya), a biosimilar monoclonal antibody product used for bone-related indications; the service is an injectable biologic medication typically administered via subcutaneous injection in outpatient infusion clinics, physician offices, or ambulatory procedure settings and is reported for the specific biosimilar product and dose.
For related coverage guidance, see recent payer policy updates: B-Hemolytic Streptococcus Testing, Human Immunodeficiency Virus (HIV) — Coverage Criteria for Testing and Resistance Assays, Hepatitis Testing (A, B, C, D) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs Q5161 policy alerts
Get alerted when payer policies referencing Q5161 are released or updated.
Monitor payer policy activity